UC Staff Senate election opens May 2
Review candidates now to see who is running in the 2022 election
Event Information (passed)
Staff Senate elections run from May 2-13, 2022.
All UC staff not principally charged with teaching, including part-time and full-time staff, are eligible to vote. Staff will be sent links to the election system when voting is open.
With 91 candidates running for 35 open positions, take the time now to review all candidates as you prepare for voting. While candidates are listed by VP area with the most votes will fill open VP seats, all candidates can be considered for 12 At-Large seats also up for election.
Staff should consider all candidates in all VP areas when casting up to 35 votes in the election.
Candidates for election received approval from their supervisor to run for Staff Senate with elected senators serving two-year terms. Elected senators attend senate and assigned committee meetings and follow the Staff Senate Bylaws.
The Staff Senate is an advisory body to the UC President and university administration. Staff Senate endeavors to have a duly representative and diverse membership with equitable representation among various colleges, divisions, and departments.
The UC Staff Senate serves the university by promoting, protecting, and representing the interests and perspective of university staff.
Tags
Related Stories
UC faculty and staff among Rising Star leadership honorees
January 5, 2026
Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.
Top six 2025 nephrology drug approvals
January 5, 2026
“2025 has been a landmark year for kidney disease therapeutics, marked by a comprehensive slate of FDA approvals covering endothelin-receptor blockade, complement inhibition, GLP-1-based metabolic protection, and B-cell-directed therapy,” Prakash Gudsoorkar, MD, associate professor of clinical medicine at the University of Cincinnati College of Medicine and staff nephrologist at UC Health, recently told MedCentral.